Physician profile

Thomas J Mueller

Urology · Linwood, NJ

NPI 1003029836

$1,068,866.94

in general payments reported to CMS, 2019-2025

41 companies · $250K in 2025

The $250K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$417,515.64
Long Term Medical Supply Or Device Loan$51,000.00
Consulting Fee$50,637.50
Travel and Lodging$29,148.79
Food and Beverage$9,930.23
Education$35.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Teleflex LLC $690,383.68 2020-2025 Urolift, Barrigel
Neotract INC. $257,325.66 2019-2020
Angiodynamics, INC. $51,000.00 2025 Nanoknife
Procept Biorobotics Corporation $42,599.82 2021-2025 Aquabeam System
Calyxo, INC. $18,439.89 2022-2025 Cvac Aspiration System
Srs Medical Systems, INC. $4,159.20 2019
Uromedica, Incorporated $2,184.66 2019
Astellas Pharma US INC $746.53 2019-2025 Xtandi
Boston Scientific Corporation $278.09 2019-2025 Ams 700
Histosonics, INC. $249.38 2025
Medtronic, INC. $169.76 2021-2025 Interstim
Janssen Scientific Affairs, LLC $133.29 2025 Erleada
Coloplast Corp $132.98 2020-2021
Antares Pharma, INC. $127.97 2019-2025 Xyosted
Tolmar Pharmaceuticals, INC. $70.47 2019-2021
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $68.14 2019-2020
Bayer Healthcare Pharmaceuticals INC. $65.43 2020-2025
Medtronic USA, INC. $60.59 2020
Janssen Biotech, INC. $54.13 2019
Astrazeneca Pharmaceuticals LP $49.76 2022-2025 Imfinzi
Arrow International, INC. $46.67 2022
Ferring Pharmaceuticals INC. $43.12 2020
Amgen INC. $40.45 2019
E.R. Squibb & Sons, L.L.C. $40.22 2019-2021
Dentsply Ih Ab $38.55 2024 Lofric
Abbvie INC. $38.31 2020-2021
Dendreon Pharmaceuticals LLC $34.63 2021-2025 Provenge
Merck Sharp & Dohme LLC $29.79 2021
Myovant Sciences INC. $28.19 2021-2022
Myriad Genetic Laboratories, INC. $27.67 2021
Verity Pharmaceuticals INC. $27.22 2021-2025 Trelstar
Endo Pharmaceuticals INC. $24.25 2019-2021
Laborie Medical Technologies Corp. $19.60 2025 Optilume Bph Drug Coated Balloon Catheter
Palette Life Sciences, INC. $18.65 2021
Sumitomo Pharma America, INC. $17.82 2025 Gemtesa
Novartis Pharmaceuticals Corporation $17.66 2025
Clinigen, INC. $16.34 2021
Clovis Oncology, INC. $15.30 2022
Clarus Therapeutics INC. $14.49 2021
Urovant Sciences INC $14.32 2021
Urogen Pharma, INC. $14.26 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas J Mueller

$1,068,866.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Teleflex LLC
Context
The $250K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/90583/thomas-j-mueller

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.